Angiotensin II receptor antagonists and receptor subtypes.
Recently discovered nonpeptide angiotensin II receptor antagonists represent a new class of potential drugs for the treatment of hypertension and congestive heart failure. Further, these antagonists have been successfully used as selective research tools for physiologic studies of angiotensin H and defining angiotensin II receptor subtypes.
Wong
P C
PC
Du Pont Merck Pharmaceutical Company, Experimental Station, Wilmington, DE 19880-0400, USA.
Chiu
A T
AT
Duncia
J V
JV
Herblin
W F
WF
Smith
R D
RD
Timmermans
P B
PB